Browse by author
Lookup NU author(s): Carl Morland, Emeritus Professor Harry Gilbert
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Glycosidase inhibition is a key process both in the pursuit of new therapeutic agents and in the drive to understand transition-state stabilisation by these remarkable enzymes. That isofagomine lactam (1) is an equally potent inhibitor of β-glucosidases and β-mannosidases (despite possessing a carbonyl group) adds to the emerging view that mannosidases and glucosidases harness distinct transition states; the β2,5 conformation for some retaining mannosidases and the 4W3 for glucosidases, both of which place O2 pseudo-equatorially.
Author(s): Vincent F, Gloster TM, Macdonald J, Morland C, Stick RV, Dias FMV, Prates JAM, Fontes CMGA, Gilbert HJ, Davies GJ
Publication type: Article
Publication status: Published
Journal: ChemBioChem
Year: 2004
Volume: 5
Issue: 11
Pages: 1596-1599
ISSN (print): 1439-4227
ISSN (electronic): 1439-7633
Publisher: Wiley - VCH Verlag GmbH & Co. KGaA
URL: http://dx.doi.org/10.1002/cbic.200400169
DOI: 10.1002/cbic.200400169
PubMed id: 15515081
Altmetrics provided by Altmetric